61 reports

  • INDIA MOBILE CARDIAC TELEMETRY SYSTEMS MARKET REVENUE AND FORECASTS TO 2027 (US$ THOUSAND)
  • 9.3.8.1 India Mobile Cardiac Telemetry Systems Market Revenue and Forecasts to 2027 (US$ Thousand)

Additionally, congenital and hereditary genetic diseases have become a significant burden in India.

  • Patient Monitoring
  • Forecast
  • Market Size
  • BioTelemetry Inc.
  • Medicomp, Inc.
  • OVERVIEW

They are used for the diagnosis of recurrent episodes of palpitations or syncope, long-term monitoring of patients who are at a risk of AF, and risk stratification of patients with sustained myocardial infarction (MI) and certain genetic disorders.

  • Patient Monitoring
  • World
  • Forecast
  • GE Healthcare Limited
  • Medtronic, Inc.

Additionally, congenital and hereditary genetic diseases have become a significant burden in India.

  • Patient Monitoring
  • Forecast
  • Market Size
  • Abbott
  • Boston Scientific Corporation

The functioning of the brain and nervous system is severely affected by various autoimmune diseases and neurological disorders such as Alzheimer' s disease, dementia, MS, encephalitis, genetic brain disorders, brain tumors, Parkinson' s disease, a

  • Patient Monitoring
  • Forecast
  • Compumedics Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation

ADPKD IS ONE OF THE MOST COMMON, LIFE-THREATENING GENETIC DISEASES, DIAGNOSED IN ##, ## AMERICANS.

  • Patient Monitoring
  • East Asia
  • Market Size
  • Air Liquide S.A.
  • Fisher & Paykel Healthcare Corp. Limited

THE DISEASED POPULATION IS THE POPULATION SUFFERING FROM A PARTICULAR DISEASE OR CONDITION.

  • Patient Monitoring
  • China
  • East Asia
  • Philips Respironics, Inc.
  • ResMed Inc.

ADPKD IS ONE OF THE MOST COMMON, LIFE-THREATENING GENETIC DISEASES, DIAGNOSED IN ##, ## AMERICANS.

  • Patient Monitoring
  • Compumedics Limited
  • Fukuda Denshi Co., Ltd.
  • Philips Respironics, Inc.
  • Teijin Limited

BRUGADA SYNDROME IS A GENETIC DISEASE THAT PREDISPOSES TO HEART ATTACK OR SUDDEN DEATH DUE TO MALIGNANT VENTRICULAR TACHYARRHYTHMIA.

  • Patient Monitoring
  • Southern Europe
  • Spain
  • Market Size
  • Boston Scientific Corporation

DUCHENNE MUSCULAR DYSTROPHY IS A GENETIC MUSCLE WASTING DISEASE THAT BEGINS IN CHILDHOOD AND MAINLY AFFECTS BOYS.

  • Patient Monitoring
  • Northern Europe
  • United Kingdom
  • Market Size
  • LiDCO Group Plc

Urine Single Test Strips Genetic Testing Acquired Gene or Chromosome Alterations THIS SEGMENT COMPRISES OF REAGENTS EMPLOYED FOR GENETIC TESTING TO DETECT CANCER CAUSING OR RELATED ALTERATIONS SUCH AS K-RAS, BRCA ##+##, TELOMERASE AND HER-##/ NEU (HUMAN EPIDERMAL GROWTH F

  • Patient Monitoring
  • Latin America
  • Mexico
  • North America
  • Forecast

HOFFMANN-LA ROCHE LTD LED THE CLINICAL CHEMISTRY MARKET WITH A ##. ##% SHARE, FOLLOWED BY BECKMAN COULTER INC AND SIEMENS HEALTHCARE GMBH WITH ##. ##% AND ##. ##% RESPECTIVELY. ## Genetic Testing Market, Russia ##. ## GENETIC TESTING MARKET, RUSSIA, REVENUE MIX ($M), 2017 FIGURE ##:

  • Patient Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • bioMerieux S.A.

DEVICES INTENDED TO BE USED IN THE DIAGNOSIS OF INFECTIOUS DISEASES, CANCER, AND HUMAN GENETIC TESTING IS INCLUDED UNDER CLASS C DEVICES.

  • Patient Monitoring
  • World
  • Market Size
  • DexCom, Inc.
  • Medtronic, Inc.
  • 5 BRAIN MONITORING DEVICES GLOBAL MARKET, BY APPLICATIONS

In addition the research group has worked with Alzheimer' s disease consortiums to look at genetic overlap between stroke and Alzheimer' s disease.

  • Patient Monitoring
  • World
  • Market Size
  • Compumedics Limited
  • Medtronic, Inc.
  • Introduction

Chronic neurological disorders such as epilepsy can be caused by head injury, complications during childbirth, and genetic disorders that affect the brain.

  • Patient Monitoring
  • World
  • Compumedics Limited
  • Natus Medical Incorporated
  • Nihon Kohden Corporation

COSTS OF RECENTLY LAUNCHED PRENATAL GENETIC TESTS Table ## : CURRENTLY AVAILABLE NGS PLATFORMS FOR NIPT Table ## : COMMERCIALLY AVAILABLE NGS PLATFORMS FOR CFDNA TESTS Table ## : COSTS OF COMMERCIAL TESTS AVAILABLE FOR NIPT OF TRISOMIES Table ## : GENETIC DISORDERS DETECTE

  • Fetal Monitoring
  • Patient Monitoring
  • World

Also, women belonging to specific ethnic groups are genetically prone to preterm births.

  • Humidifier
  • Patient Monitoring
  • North America
  • United States
  • ResMed Inc.

These tests explore genetic materials such as DNA, RNA, and genes, offering vital information on metabolic pathways, drug metabolism, and disease progression.

  • Patient Monitoring
  • North America
  • United States
  • Market Size
  • Zoetis Inc.

These tests explore genetic materials such as DNA, RNA, and genes, offering vital information on metabolic pathways, drug metabolism, and disease progression.

  • Patient Monitoring
  • North America
  • United States
  • World
  • Market Size

HAE IS A RARE, GENETIC DISORDER ESTIMATED TO AFFECT ABOUT ## IN ##, ## TO ## IN ##, ## PEOPLE WORLDWIDE.

  • Patient Monitoring
  • Respiratory Monitoring
  • North America
  • Demand
  • Masimo Corporation

HAE is a rare, genetic disorder estimated to affect about ## in ##, ## to ## in ##, ## people worldwide.

  • Patient Monitoring
  • Respiratory Monitoring
  • United States
  • Demand
  • Edwards Lifesciences Corporation

Spark Therapeutics, based in Philadelphia, Pennsylvania, USA, is a fully integrated company committed to discovering, developing and delivering gene therapies for genetic diseases, including blindness, haemophilia, lysosomal storage disorders and neurodegenerative

  • Diabetes Monitoring
  • Patient Monitoring
  • United States
  • Demand
  • Roche Group

ADPKD is one of the most common, life-threatening genetic diseases, diagnosed in ##, ## Americans.

  • Medical Device
  • Patient Monitoring
  • Japan
  • Market Size
  • Teijin Limited

Easton Capital seeks to invest in companies focusing on therapeutic areas of cardiovascular, hematological disorders, oncology, immunology and genetic disorders.

  • Cardiology
  • Patient Monitoring
  • United States
  • M&A
  • Boston Scientific Corporation

In April, Sanofi and Alnylam agreed to conclude the research and option phase of the companies' 2014 RNAi therapeutics alliance in rare genetic diseases.

  • Diagnostics
  • Medical Device
  • Patient Monitoring
  • United States
  • Company

MOST OF THE WORLD' S ##, ## TO ##, ## RARE DISEASES ARE GENETIC.

  • Hospital
  • Patient Monitoring
  • Canada
  • North America
  • Medtronic, Inc.

In January, 2018, Sanofi and Alnylam announced a strategic restructuring of their RNAi therapeutics alliance to streamline and optimize development and commercialization of certain products for the treatment of rare genetic diseases.

  • Patient Monitoring
  • France
  • United States
  • Demand
  • Sanofi S.A.

PROFESSOR LI CONTINUES, CANCER IS ONE OF THE DISEASES THAT SERIOUSLY THREATENS HUMAN LIFE.

  • Clinical Trial
  • Patient Monitoring
  • China
  • East Asia
  • Forecast

MOST OF THE WORLD' S ##, ## TO ##, ## RARE DISEASES ARE GENETIC.

  • Patient Monitoring
  • Canada
  • North America
  • Market Size
  • Philips Respironics, Inc.

TODAY THERE ARE STILL MILLIONS OF PATIENTS SUFFERING FROM WRONGLY OR UNDIAGNOSED GENETIC DISEASES.

  • Infectious Disease
  • Patient Monitoring
  • Germany
  • Western Europe
  • Forecast

IN JANUARY, 2018, SANOFI AND ALNYLAM ANNOUNCED A STRATEGIC RESTRUCTURING OF THEIR RNAI THERAPEUTICS ALLIANCE TO STREAMLINE AND OPTIMIZE DEVELOPMENT AND COMMERCIALIZATION OF CERTAIN PRODUCTS FOR THE TREATMENT OF RARE GENETIC DISEASES.

  • Neuromodulation Device
  • Patient Monitoring
  • France
  • Western Europe
  • Sanofi S.A.